Drug Research (formerly Arzneimittelforschung) is an international peer-reviewed journal with expedited processing times presenting the very latest research results related to novel and established drug molecules and the evaluation of new drug development. A key focus of the publication is translational medicine and the application of biological discoveries in the development of drugs for use in the clinical environment. Articles and experimental data from across the field of drug research address not only the issue of drug discovery, but also the statistical methods for evaluating results from experimental investigations and clinical trials.
Publishing twelve times a year, Drug Research includes original research articles and modelling approaches as well as reviews, commentaries and short communications in the following areas:
• analytics applied to clinical trials
• medicinal chemistry and drug formulations
• biochemistry and molecular biology
• clinical and experimental pharmacology
• drug interactions
• pharmacokinetics and systems pharmacology
• toxicology and early development
Be a winner! Submit to the journal for the Drug Research Awards – recognizing ground-breaking contributions in translational medicine! Click here to learn more.
Most Innovative Paper Award
Drug Research has been at the forefront of innovation, research and development ever since its inception back in 1951. To honor ground-breaking contributions and their authors in over 65 years of drug development research the journal has recorded, Thieme, the publisher of Drug Research, has decided to award prizes to the most innovative original article and to the most innovative review of the year.
We are proud to announce the 2017 winners of our Drug Research Most Innovative Paper Award today:
Most Innovative Review
Action Plan for Prolongation of Nephrogenesis in Preterm and Growth Restricted Babies: Explore Ultrastructure of the Nephrogenic Zone, Identify a Molecular Target, Select a Viable Drug and Find a Path for Administration by Will W. Minuth
Most Innovative Original Article
Balanced Coagonist of GLP-1 and Glucagon Receptors Corrects Dyslipidemia by Improving FGF21 Sensitivity in Hamster Model by Vishal Patel, Amit Joharapurkar, Samadhan Kshirsagar, Hiren M. Patel, Dheerendra Pandey, Dipam Patel, Brijesh Sutariya, Maulik Patel, Rajesh Bahekar, Mukul R. Jain
We are delighted to grant free access to the full articles.